-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
To_profile_the_landscape_of_sebaceous_tumours_WES
Study
EGAS00001003553
-
Amplicon_based_sequencing_of_drug_resistant_lung_cancer_cell_lines
Study
EGAS00001001675
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
Tumor suppressor miR-133a modulates the prostate cancer epigenome by repressing BAZ2A
Study
EGAS00001000568
-
Chromosomal copy number heterogeneity predicts survival rates across cancers
Study
EGAS00001004702
-
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells
Study
EGAS00001001310
-
ENU_LS_411N_TripleTherapy
Study
EGAS00001001777
-
ENU_HT_29_BRAF_Triple_Therapy_Clones
Study
EGAS00001001778
-
Enrichment of homologous recombination repair alteration in prostate cancer brain metastases
Study
EGAS00001005091
-
The clonal and mutational evolution spectrum of primary triple negative breast cancers
Study
EGAS00001000132
-
Somatic_Genetics_of_lesions_from_a_POT1_patient
Study
EGAS00001001343
-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
Breast Cancer - Subtype defined by an amplification of the HER2 gene
Study
EGAS00001001431
-
Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations
Study
EGAS00001004752
-
Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency
Study
EGAS00001000149
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
A comprehensive assessment of somatic mutation detection in cancer using whole genome sequencing
Study
EGAS00001001539
-
Whole genome sequencing of primary and metastatic Melanoma cases in an Australian cohort.
Study
EGAS00001001552
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
The_genetic_evolution_of_precursor_lesions_in_pancreatic_cancer
Study
EGAS00001001573
-
Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation, pronostic value of high LOH genomic score and predictive value of HRDetect (microarray)
Study
EGAS00001004755
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
In_Situ_Transcription_whole_genome_sequencing
Study
EGAS00001001971